Hurry up to get the early bird price for ESC Liverpool! You have until 14 September!Isar Aerospace achieves first launch to orbit from continental Europe and in TWISH we celebrate the 60th anniversary of Star Trek, a show that brought humanism into science fiction. Then, it’s time for the news:SWEDEN: General elections update plus early voting screwupGERMANY: AfD wins in Saxony-AnhaltINTERNATIONAL: IgNobel prizes of 2026UK: Discrepancy between public perception of crime rates and actual

Eye On The Night Sky For Tuesday, September 8

Guest: Jonathon B. Cohen, MD, MS As chemotherapy-free approaches for mantle cell lymphoma continue to evolve, important questions remain about how best to incorporate them into clinical practice. Here to help shed light on the key unknowns surrounding patient selection, treatment sequencing, and the potential implications of using targeted and immune therapies in the frontline setting is Dr. Jonathon Cohen. He’s a board-certified hematologist and medical oncologist at Emory Winship

In this episode, Ross Stewart from the Center for Biodiversity and Genomics discusses the innovative BugQuest project, which uses Malaise traps and DNA barcoding to study insect diversity across Canada. Discover how citizen science, advanced sequencing, and creative outreach are transforming entomology research. BugQuest: https://bioscan.life/bugquest/ University of Guelph News (April 2026):

Host: Shelina Ramnarine, PhD Guest: Christopher Bunick, MD, PhD, FAAD Hand atopic dermatitis and other subtypes of chronic hand eczema can present similarly, but differences in their underlying drivers can have important implications for diagnosis and treatment. Review which clinical clues can point to hand atopic dermatitis, why underlying immune drivers matter, and how an accurate diagnosis can help support better long-term disease control with Dr. Shelina Ramnarine and Dr

Host: Brian P. McDonough, MD, FAAFP Guest: Michael Yip, PhD As surgical robots evolve from following a surgeon’s movements to learning surgical skills, new possibilities are emerging for what they could take on in the OR. Dr. Michael Yip joins Dr. Brian McDonough to unpack where autonomous assistance, remote collaboration, and even humanoid platforms could fit into surgery—and the ethical, safety, and regulatory questions that will shape their path into clinical practice. Dr. Yip

Jess received her Bachelors in Psychology with Honors in 2007 from the University of Kentucky. She subsequently earned her MS (2010) and Ph.D. (2013) in Experimental Psychology, both completed in Thomas Zentall’s laboratory at the University of Kentucky. She was a Lecturer of Psychology at the University of Florida from 2013-2017, and at Georgia Southern University from 2017-2020. Currently, she is an Associate Professor in the department of psychology at Auburn University at Montgomery.Her research

This week, we’re exploring the blood-filled art of James Gillray. We uncover the world of excretory medicine – from gentle emetics to breathing a vein. And we dig into the uncouth, evocative and sometimes obscene work of Georgian caricaturists – making a mockery of the strange practices of eighteenth century doctors and their patients._______________ Follow us on: Bluesky - @physiciansgallery Instagram - @physiciansgallery TikTok - @physiciansgallery Facebook -

This week for Dear Science, we chat with our expert, Dr Cushla McGoverin, about Narwhals, exercising and sleep, and El Niño.Thanks to MOTAT - Home of Powerful Play!

Mark Van Oene has just taken over as CEO of Pacific Biosciences, and Mendelspod is his first interview in the new job. He began his career as a scientist studying cystic fibrosis genetics at Toronto’s SickKids, then spent fifteen years at Illumina, rising from its first sales rep in Canada to Chief Commercial Officer. He joined PacBio in 2021 as COO and has spent the past five years helping build the product portfolio he now inherits as CEO.He joins us today with a clear message: PacBio is

Eye On The Night Sky For Monday, September 7

In Episode 54 of The League, Benoy Thanjan and David Magid examine how clean energy is becoming increasingly connected to national security, grid resilience and government policy. They discuss Michigan’s new statewide permitting process, which could overcome local zoning barriers and accelerate utility-scale solar development. They also explore Westinghouse’s proposed nuclear microreactor at Fort Drum and its potential to strengthen military energy resilience. The conversation then turns to the

Science looks at the much-publicized rash of attacks on yachts and other oceangoing vessels by killer whales and finds the whales don’t really seem to [...]The post Boat-wrecking orcas might only be playing. first appeared on The Guild of Scientific Troubadours.

Following the Midterm Elections, policy changes are scheduled to go into effect—and for community health centers, preparing for Medicaid coverage changes can’t wait until December. In this episode of the Coleman Associates Innovation Podcast, COO Allison Dubois and CEO Gralyn Jacques join Amanda to talk about what health centers can do now to help eligible patients stay covered while preparing for the operational and financial impact ahead. In this episode, we'll talk about identifying patien...

608 - Sneaky Bubbles - Samuel Mann catches Mawera Karetai after she snuck through town. This show was broadcast on OAR 105.4FM Dunedin - oar.org.nz

Leave it to the robots.

An extended Climate Matters interview with Nadine Hura

Climate Matters is an audio version of Resilienz Ltd's Climate Matters newsletter, that gives intriguing insights into climate breakdown and climate recovery.

Guest: Jonathon B. Cohen, MD, MS As chemotherapy-free approaches for mantle cell lymphoma continue to evolve, important questions remain about how best to incorporate them into clinical practice. Here to help shed light on the key unknowns surrounding patient selection, treatment sequencing, and the potential implications of using targeted and immune therapies in the frontline setting is Dr. Jonathon Cohen. He’s a board-certified hematologist and medical oncologist at Emory Winship

What happens when vitreous hemorrhage (VH) secondary to non-tractional PDR doesn't clear on its own? And does preoperative anti-VEGF actually change surgical outcomes? Maria Berrocal, MD, speaks with Sumit Sharma, MD, about a retrospective case series of 360 patients who underwent vitrectomy for non-clearing VH without tractional elements, examining whether preoperative anti-VEGF injection affects the risk of postoperative rebleeding, when to consider repeat vitrectomy, and how both